The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants
Abstract
BACKGROUND: Chronic lung disease remains a major problem in neonatal intensive care units. Persistent inflammation in the lungs is the most likely underlying pathogenesis. Corticosteroids have been used to either prevent or treat chronic lung disease because of their potent anti-inflammatory effects. OBJECTIVES: To examine the relative benefits and adverse effects of postnatal corticosteroids commenced within the first seven days of life to preterm infants at risk of developing chronic lung disease. SEARCH METHODS: We sought randomised controlled trials (RCTs) of postnatal corticosteroid therapy from the Cochrane Central Register of Controlled Trials (CENTRAL, 2013, Issue 8), MEDLINE (1966 to August 2013), handsearching paediatric and perinatal journals, and by examining previous review articles and information received from practising neonatologists. We contacted authors of all studies, where possible, to confirm details of reported follow-up studies, or to obtain any information about long-term follow-up where none had been reported. SELECTION CRITERIA: We selected RCTs of postnatal corticosteroid treatment within the first seven days of life (early) in high-risk preterm infants for this review. Most studies evaluated the use of dexamethasone but we also included studies that assessed hydrocortisone, even if it was used primarily to manage hypotension. DATA COLLECTION AND ANALYSIS: We extracted and analysed data regarding clinical outcomes that included mortality, chronic lung disease, death or chronic lung disease, failure to extubate, complications during the primary hospitalisation, and long-term health outcomes. MAIN RESULTS: Twenty-nine RCTs enrolling a total of 3750 participants were eligible for inclusion in this review. The overall risk for bias was probably low as all were randomised controlled trials, and most trials have used rigorous methods. There were significant benefits for the following outcomes: lower rates of failure to extubate and decreased risks of chronic lung disease at both 28 days and 36 weeks' postmenstrual age, death or chronic lung disease at 28 days and 36 weeks' postmenstrual age, patent ductus arteriosus and ROP, including severe ROP. There were no significant differences in the rates of neonatal or subsequent mortality, infection, severe intraventricular haemorrhage, periventricular leukomalacia, necrotising enterocolitis or pulmonary haemorrhage. Gastrointestinal bleeding and intestinal perforation were important adverse effects. The risks of hyperglycaemia, hypertension, hypertrophic cardiomyopathy and growth failure were also increased. In the 12 trials that reported late outcomes, several adverse neurological effects were found at follow-up examinations, including developmental delay (not defined), cerebral palsy and abnormal neurological examination. However, major neurosensory disability was not significantly increased, either overall in the seven studies where this outcome could be determined, or in the two individual studies where the rates of cerebral palsy or abnormal neurological examination were significantly increased. Moreover, the rates of the combined outcomes of death or cerebral palsy, or of death or major neurosensory disability, were not significantly increased. Dexamethasone was used in most studies (n = 20); only nine studies used hydrocortisone. In subgroup analyses by type of corticosteroid, most of the beneficial and harmful effects were attributable to dexamethasone; hydrocortisone had little effect on any outcomes except for an increase in intestinal perforation and a borderline reduction in patent ductus arteriosus. AUTHORS' CONCLUSIONS: The benefits of early postnatal corticosteroid treatment (≤ 7 days), particularly dexamethasone, may not outweigh the adverse effects of this treatment. Although early corticosteroid treatment facilitates extubation and reduces the risk of chronic lung disease and patent ductus arteriosus, it causes short-term adverse effects including gastrointestinal bleeding, intestinal perforation, hyperglycaemia, hypertension, hypertrophic cardiomyopathy and growth failure. Long-term follow-up studies report an increased risk of abnormal neurological examination and cerebral palsy. However, the methodological quality of the studies determining long-term outcomes is limited in some cases; the surviving children have been assessed predominantly before school age, and no study has been sufficiently powered to detect important adverse long-term neurosensory outcomes. There is a compelling need for the long-term follow-up and reporting of late outcomes, especially neurological and developmental outcomes, among surviving infants who participated in all randomised trials of early postnatal corticosteroid treatment. Hydrocortisone in the doses and regimens used in the reported RCTs has few beneficial or harmful effects and cannot be recommended for the prevention of chronic lung disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Jacob, M. (1989) · Health Education Journal · doi:10.1177/001789698904800401 · Cited by 3,090
Caffeine Therapy for Apnea of Prematurity
Schmidt, B., Roberts, R. S., Davis, P., Doyle, L. W., Barrington, K. J., Ohlsson, A., Solimano, A., & Tin, W. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054065 · Cited by 1,208
Self-citationOutcomes at School Age after Postnatal Dexamethasone Therapy for Lung Disease of Prematurity
Yeh, T. F., Lin, Y. J., Lin, H. C., Huang, C. C., Hsieh, W. S., Lin, C. H., & Tsai, C. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032089 · Cited by 596
A Controlled Trial of Dexamethasone in Preterm Infants at High Risk for Bronchopulmonary Dysplasia
Cummings, J. J., D'Eugenio, D. B., & Gross, S. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906083202301 · Cited by 483
Adverse Effects of Early Dexamethasone Treatment in Extremely-Low-Birth-Weight Infants
Stark, A. R., Carlo, W. A., Tyson, J. E., Papile, L.-A., Wright, L. L., Shankaran, S., Donovan, E. F., Oh, W., Bauer, C. R., Saha, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101113440203 · Cited by 479
Self-citationWatterberg, K. L., Gerdes, J. S., Cole, C. H., Aucott, S. W., Thilo, E. H., Mammel, M. C., Couser, R. J., Garland, J. S., Rozycki, H. J., Leach, C. L., et al. (2004) · Pediatrics · doi:10.1542/peds.2004-1159 · Cited by 432
Early Dexamethasone Therapy in Preterm Infants: A Follow-up Study
Yeh, T. F., Lin, Y. J., Huang, C. C., Chen, Y. J., Lin, C. H., Lin, H. C., Hsieh, W. S., & Lien, Y. J. (1998) · Pediatrics · doi:10.1542/peds.101.5.e7 · Cited by 418
Antenatal Glucocorticoid Treatment and Cystic Periventricular Leukomalacia in Very Premature Infants
Baud, O., Foix-L'Helias, L., Kaminski, M., Audibert, F., Jarreau, P.-H., Papiernik, E., Huon, C., Lepercq, J., Dehan, M., & Lacaze-Masmonteil, T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910143411604 · Cited by 414
Controlled Trial of Dexamethasone in Respirator-Dependent Infants with Bronchopulmonary Dysplasia
Avery, G. B., Fletcher, A. B., Kaplan, M., & Brudno, D. S. (1985) · Pediatrics · doi:10.1542/peds.75.1.106 · Cited by 379
O'Shea, T. M., Kothadia, J. M., Klinepeter, K. L., Goldstein, D. J., Jackson, B. G., Weaver, R. G., & Dillard, I. A. R. G. (1999) · Pediatrics · doi:10.1542/peds.104.1.15 · Cited by 376
Early postnatal dexamethasone treatment and increased incidence of cerebral palsy
Shinwell, E. S., Karplus, M., Reich, D., Weintraub, Z., Blazer, S., Bader, D., Yurman, S., Dolfin, T., Kogan, A., Dollberg, S., et al. (2000) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/fn.83.3.f177 · Cited by 368
CONTROLLED TRIAL OF DEXAMETHASONE THERAPY IN INFANTS WITH BRONCHOPULMONARY DYSPLASIA
Mammel, M., Johnson, D., Green, T., & Thompson, T. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92139-6 · Cited by 307
Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants
Halliday, H., Ehrenkranz, R., & Doyle, L. (2003) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001146 · Cited by 303
Self-citationHalliday, H. L., Ehrenkranz, R. A., & Doyle, L. W. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001144 · Cited by 271
Self-citationProphylaxis Against Early Adrenal Insufficiency to Prevent Chronic Lung Disease in Premature Infants
Watterberg, K. L., Gerdes, J. S., Gifford, K. L., & Lin, H.-M. (1999) · Pediatrics · doi:10.1542/peds.104.6.1258 · Cited by 256
Evidence of Early Adrenal Insufficiency in Babies Who Develop Bronchopulmonary Dysplasia
Watterberg, K. L., & Scott, S. M. (1995) · Pediatrics · doi:10.1542/peds.95.1.120 · Cited by 237
Ng, P. C., Lee, C. H., Bnur, F. L., Chan, I. H. S., Lee, A. W. Y., Wong, E., Chan, H. B., Lam, C. W. K., Lee, B. S. C., & Fok, T. F. (2006) · Pediatrics · doi:10.1542/peds.2005-0869 · Cited by 217
Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants
Halliday, H. L., Ehrenkranz, R. A., & Doyle, L. W. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001145.pub2 · Cited by 205
Self-citationHalac, E., Halac, J., Bégué, E. F., Casañas, J. M., Indiveri, D. R., Petit, J. F., Figueroa, M. J., Olmas, J. M., Rodriíguez, L. A., Obregón, R. J., et al. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)72461-6 · Cited by 191
Yeh, T. F., Lin, Y. J., Hsieh, W. S., Lin, H. C., Lin, C. H., Chen, J. Y., Kao, H. A., & Chien, C. H. (1997) · Pediatrics · doi:10.1542/peds.100.4.e3 · Cited by 184
Influence of Postnatally Administered Glucocorticoids on Rat Lung Growth
Tschanz, S. A., Damke, B. M., & Burri, P. H. (1995) · Neonatology · doi:10.1159/000244241 · Cited by 184
A CONTROLLED TRIAL OF HYDROCORTISONE THERAPY IN INFANTS WITH RESPIRATORY DISTRESS SYNDROME
Baden, M., Bauer, C. R., Colle, E., Klein, G., Taeusch, H. W., & Stern, L. (1972) · Pediatrics · doi:10.1542/peds.50.4.526 · Cited by 179
A Multicenter Trial of Two Dexamethasone Regimens in Ventilator-Dependent Premature Infants
Papile, L.-A., Tyson, J. E., Stoll, B. J., Wright, L. L., Donovan, E. F., Bauer, C. R., Krause-Steinrauf, H., Verter, J., Korones, S. B., Lemons, J. A., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804163381604 · Cited by 172
Self-citationInflammatory mediators and bronchopulmonary dysplasia.
Groneck, P., & Speer, C. P. (1995) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/fn.73.1.f1 · Cited by 171
Watterberg, K. L., Shaffer, M. L., Mishefske, M. J., Leach, C. L., Mammel, M. C., Couser, R. J., Abbasi, S., Cole, C. H., Aucott, S. W., Thilo, E. H., et al. (2007) · Pediatrics · doi:10.1542/peds.2006-3158 · Cited by 162
Bhuta, T., & Ohlsson, A. (1998) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.79.1.f26 · Cited by 145
Peltoniemi, O. M., Kari, M. A., Heinonen, K., Saarela, T., Nikolajev, K., Andersson, S., Voutilainen, R., & Hallman, M. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.12.040 · Cited by 141
Dexamethasone Therapy Increases Infection in Very Low Birth Weight Infants
Stoll, B. J., Temprosa, M. G., Tyson, J. E., Papile, L. A., Wright, L. L., Bauer, C. R., Donovan, E. F., Korones, S. B., Lemons, J. A., Fanaroff, A. A., et al. (1999) · PEDIATRICS · doi:10.1542/peds.104.5.e63 · Cited by 123
Self-citationBrozanski, B. S., Jones, J., Gilmour, C., Balsan, M. J., Vazquez, R. L., Israel, B. A., Newman, B., Mimouni, F. B., & Guthrie, R. D. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70410-8 · Cited by 121
Weichsel, M. E. (1977) · Annals of Neurology · doi:10.1002/ana.410020503 · Cited by 120
Sequelae of Early Steroid Administration to the Newborn Infant
Fitzhardinge, P. M., Eisen, A. H., Lejtenyi, C., Metrakos, K., & Ramsay, M. (1974) · PEDIATRICS · doi:10.1542/peds.53.6.877 · Cited by 118
Kazzi, N. J., Brans, Y. W., & Poland, R. L. (1990) · PEDIATRICS · doi:10.1542/peds.86.5.722 · Cited by 116
Ohlsson, A., Calvert, S., Hosking, M., et al. (1992) · Acta Paediatrica · doi:10.1111/j.1651-2227.1992.tb12096.x · Cited by 110
Efird, M. M., Heerens, A. T., Gordon, P. V., Bose, C. L., & Young, D. A. (2004) · Journal of Perinatology · doi:10.1038/sj.jp.7211193 · Cited by 108
Clinical Trials of Postnatal Corticosteroids: Inhaled and Systemic
Halliday, H. L. (1999) · Neonatology · doi:10.1159/000047044 · Cited by 104
Self-citationDoyle, L. W., Ehrenkranz, R. A., & Halliday, H. L. (2010) · Neonatology · doi:10.1159/000286212 · Cited by 99
Self-citationEffect of dexamethasone on protein metabolism in infants with bronchopulmonary dysplasia
van Goudoever, J. B., Wattimena, J. L. D., Carnielli, V. P., Sulkers, E., DEGENHART, H. J., & Sauer, P. J. J. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70265-9 · Cited by 96
Early Postnatal Dexamethasone Therapy for the Prevention of Chronic Lung Disease
Soll, R. F. (1999) · Pediatric Research · doi:10.1203/00006450-199904020-01345 · Cited by 91
Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia.
Kari, M. A., Heinonen, K., Ikonen, R., Koivisto, M., & Raivio, K. O. (1993) · Archives of Disease in Childhood · doi:10.1136/adc.68.5_spec_no.566 · Cited by 89
Dexamethasone in neonatal chronic lung disease: pulmonary effects and intracranial complications
Noble-Jamieson, C. M., Regev, R. H., & Silverman, M. E. (1989) · European Journal of Pediatrics · doi:10.1007/bf00444135 · Cited by 80
Tapia, J. L., Ramírez‐Campillo, R., Cifuentes, J. A. B., Fabres, J. G., Hübner, M. E., Bancalari, A., Mercado, M. E., Standen, J., & Escobar, M. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70483-4 · Cited by 76
Doyle, L. W., & Davis, P. G. (2000) · Journal of Paediatrics and Child Health · doi:10.1046/j.1440-1754.2000.00481.x · Cited by 69
Self-citationThe Influence of Betamethasone and Dexamethasone on Motor Development in Young Rats
Gramsbergen, A., & Mulder, E. J. H. (1998) · Pediatric Research · doi:10.1203/00006450-199807000-00017 · Cited by 56
D’Angio, C. T., Maniscalco, W. M., Ryan, R. M., Avissar, N. E., Basavegowda, K. P., & Sinkin, R. A. (1999) · Neonatology · doi:10.1159/000014168 · Cited by 54
Nixon, P. A., Washburn, L. K., Schechter, M. S., & O’Shea, T. M. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.12.013 · Cited by 53
Romagnoli, C., Zecca, E., Vento, G., Carolis, M. P. D., Papacci, P., & Tortorolo, G. (1999) · Intensive Care Medicine · doi:10.1007/s001340050935 · Cited by 45
Walther, F. J., Findlay, R. D., & Durand, M. (2003) · Early Human Development · doi:10.1016/s0378-3782(03)00082-3 · Cited by 39
More trials on early treatment with corticosteroids are needed
Subhedar, N. V., Bennett, A. J., Wardle, S. P., & Shaw, N. J. (2000) · BMJ · doi:10.1136/bmj.320.7239.941 · Cited by 33
Effect of Dexamethasone Therapy on the Neonatal Ductus Arteriosus
Morales, P., Rastogi, A., Bez, M. L., Akintorin, S. M., Pyati, S., Andes, S., & Pildes, R. S. (1998) · Pediatric Cardiology · doi:10.1007/s002469900290 · Cited by 31
Washburn, L. K., Nixon, P. A., & O’Shea, T. M. (2006) · PEDIATRICS · doi:10.1542/peds.2006-0973 · Cited by 25
Cited by
Sweet, D. G., Carnielli, V., Greisen, G., Hallman, M., Ozek, E., Plavka, R., Saugstad, O. D., Simeoni, U., Speer, C. P., Vento, M., et al. (2013) · Neonatology · doi:10.1159/000349928 · Cited by 550
Self-citationPrediction of Bronchopulmonary Dysplasia by Postnatal Age in Extremely Premature Infants
Laughon, M. M., Langer, J. C., Bose, C. L., Smith, P. B., Ambalavanan, N., Kennedy, K. A., Stoll, B. J., Buchter, S., Laptook, A. R., Ehrenkranz, R. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201101-0055oc · Cited by 453
Self-citationEpidemiology of bronchopulmonary dysplasia
Jensen, E. A., & Schmidt, B. (2014) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.23235 · Cited by 419
Bronchopulmonary Dysplasia: Chronic Lung Disease of Infancy and Long-Term Pulmonary Outcomes
Davidson, L., & Berkelhamer, S. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6010004 · Cited by 415
Baud, O., Maury, L., Lebail, F., Ramful, D., El Moussawi, F., Nicaise, C., Zupan-Simunek, V., Coursol, A., Beuchée, A., Bolot, P., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00202-6 · Cited by 364
Metadata
- Authors
- Halliday, H. L., Ehrenkranz, R. A., & Doyle, L. W.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2009-01-21
- Issue
- 1
- Pages
- CD001146-CD001146
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W1911366939
- Cited by
- 298
- References
- 51
- Type
- reference entry
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.